Sign in

Sympathetic blocks: stellate, celiac, hypogastric and impar

Procedural · G4c · Reviewed by a board-certified pain physician on October 31, 2026

Bottom line

Pick the sympathetic target by territory: stellate for head, neck and arm; celiac for upper abdominal viscera; superior hypogastric for pelvic viscera; ganglion impar for perineum and coccyx. Deep blocks are high bleeding risk.

Key points

  1. Celiac plexus for upper abdominal viscera. It carries visceral afferent and sympathetic fibers from organs such as the pancreas; neurolysis, usually with alcohol, chemically destroys these fibers, reducing pancreatic and other upper abdominal cancer pain and lowering opioid requirements 1.
  2. Superior hypogastric plexus for pelvic viscera. It lies retroperitoneally in front of the lower L5 body and upper sacrum and supplies the bladder, uterus, vaginal fundus and rectum 21. In the original series, neurolysis gave satisfactory relief in 69% of patients with pelvic cancer pain 3.
  3. Ganglion impar for perineum and coccyx. This solitary retroperitoneal ganglion supplies the perineum, distal rectum, anus and coccyx 14. For refractory coccydynia, ganglion impar block is used more often than coccygeal nerve block, with radiofrequency techniques as further options 4.
  4. Expect sympathectomy side effects. After celiac neurolysis, unopposed parasympathetic activity commonly causes transient diarrhea, and splanchnic vasodilation can cause orthostatic hypotension 1.
  5. Stellate blocks are cervical, high-stakes procedures. In an iodinated contrast shortage, stellate blocks should be postponed unless done under ultrasound by physicians highly experienced in that technique 5.
  6. Bleeding risk is high under ASIPP. The 2024 ASIPP guideline places deep sympathetic blocks and neurolysis (stellate, thoracic, splanchnic, celiac, lumbar sympathetic, hypogastric) in the high-risk category, alongside implants, vertebral augmentation and percutaneous decompression 6.

Watch for

Bleeding-risk tiers differ by guideline: ASIPP 2024 rates deep sympathetic blocks high risk, so state which guideline you are applying when planning anticoagulant holds 6.

High-yield for the exam

  • Deep central pelvic visceral cancer pain points to the superior hypogastric plexus, not the celiac plexus 1.
  • Pancreatic and other upper abdominal cancer pain points to the celiac plexus 1.
  • Neurolytic celiac block reduces sympathetic, not parasympathetic, tone 1.
  • Ultrasound guidance is the advisory's contrast-free alternative for stellate blocks, by experienced operators 5.
  • Spinal cord stimulator and intrathecal implants also sit in ASIPP's high-risk tier 6.
  • Coccydynia is managed conservatively first with cushions, medications and pelvic floor therapy, with injections for persistent pain 7.
  • Ultrasound shows vessels and soft tissue, letting the needle be directed away from arteries during a stellate block 5.
  • The ganglion impar also supplies the distal urethra, vulva and distal third of the vagina 1.

Numbers to know

Item Value
Superior hypogastric plexus level anterior to lower L5 and upper sacrum 2
Satisfactory relief after SHP neurolysis (original series) 69% 3
Common effects after celiac neurolysis transient diarrhea, orthostatic hypotension 1
ASIPP tier for celiac neurolysis high 6

Common traps

  • Choosing a celiac block for deep pelvic visceral cancer pain 1.
  • Mistaking transient post-celiac diarrhea for a complication requiring reversal 1.
  • Proceeding with a stellate block without contrast or ultrasound expertise 5.
  • Assuming every guideline rates sympathetic blocks the same bleeding risk 6.

Practise this topic

9 more questions on this topic in the full question bank, with explanations and sources.

Sources

  1. Aman MM, et al. The American Society of Pain and Neuroscience (ASPN) best practices and guidelines for the interventional management of cancer-associated pain. J Pain Res, 2021. pmc.ncbi.nlm.nih.gov/articles/PMC8292624/
  2. Abdelghaffar NA, Farahat TE. Fluoroscopic anterior approach versus ultrasound guided superior hypogastric plexus neurolysis in cancer pelvic pain: a randomized controlled study. BMC Anesthesiol, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC9793506/
  3. de Leon-Casasola OA, Kent E, Lema MJ. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Pain, 1993. pubmed.ncbi.nlm.nih.gov/8233527/
  4. Staartjes VE, et al. Contemporary Management of Coccydynia. Neurospine, 2026. pmc.ncbi.nlm.nih.gov/articles/PMC13152700/
  5. Schuster NM, et al. Best practices for interventional pain procedures in the setting of an iodinated contrast media shortage: a multisociety practice advisory. Interv Pain Med, 2022. pmc.ncbi.nlm.nih.gov/articles/PMC11372943/
  6. Manchikanti L, et al. Perioperative management of antiplatelet and anticoagulant therapy in patients undergoing interventional techniques: 2024 updated guidelines from the American Society of Interventional Pain Physicians (ASIPP). Pain Physician, 2024. painphysicianjournal.com/current/pdf?article=Nzg3NQ%3D%3D&jo
  7. Foye PM. Coccydynia: Tailbone Pain. Phys Med Rehabil Clin N Am, 2017. pubmed.ncbi.nlm.nih.gov/28676363/

Related topics

Independent study material for the ABA Pain Medicine exam, written and reviewed by a board-certified pain physician. Not medical advice; not affiliated with the American Board of Anesthesiology.